COVID-19 vaccine prioritisation for type 1 and type 2 diabetes.
作者信息
Powers Alvin C, Aronoff David M, Eckel Robert H
机构信息
Vanderbilt Diabetes Center, Vanderbilt University Medical Center, Nashville, TN 37232-0475, USA; Division of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232-0475, USA.
Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232-0475, USA.
出版信息
Lancet Diabetes Endocrinol. 2021 Mar;9(3):140-141. doi: 10.1016/S2213-8587(21)00017-6. Epub 2021 Jan 18.
Abstract
摘要
相似文献
1
COVID-19 vaccine prioritisation for type 1 and type 2 diabetes.1型和2型糖尿病患者的新冠病毒疫苗接种优先级
Lancet Diabetes Endocrinol. 2021 Mar;9(3):140-141. doi: 10.1016/S2213-8587(21)00017-6. Epub 2021 Jan 18.
2
COVID-19 vaccine prioritisation for people with disabilities.为残疾人士优先接种新冠疫苗。
Lancet Public Health. 2021 Jun;6(6):e361. doi: 10.1016/S2468-2667(21)00093-1. Epub 2021 Apr 21.
3
Coronavirus vaccine? Join the queue.新冠疫苗？排队等着吧。
Lancet Diabetes Endocrinol. 2021 Jan;9(1):1. doi: 10.1016/S2213-8587(20)30409-5. Epub 2020 Dec 4.
4
COVID-19 Vaccine: Promoting Vaccine Acceptance.新型冠状病毒肺炎疫苗：促进疫苗接种。
Ann Intern Med. 2021 Feb;174(2):252-253. doi: 10.7326/M20-8008. Epub 2020 Dec 21.
5
FDA authorizes Pfizer-BioNTech COVID-19 vaccine.美国食品药品监督管理局批准辉瑞-生物科技公司的新冠病毒疫苗。
Med Lett Drugs Ther. 2021 Jan 11;63(1615):1-2.
6
Is It Lawful and Ethical to Prioritize Racial Minorities for COVID-19 Vaccines?将新冠疫苗接种优先分配给少数族裔是否合法且符合伦理？
JAMA. 2020 Nov 24;324(20):2023-2024. doi: 10.1001/jama.2020.20571.
7
FDA authorizes Moderna COVID-19 vaccine.美国食品药品监督管理局批准莫德纳新冠疫苗。
Med Lett Drugs Ther. 2021 Jan 25;63(1616):9-10.
8
Tackling inequitable distribution of the COVID-19 vaccine.解决新冠疫苗分配不公问题。
Br J Community Nurs. 2021 Jan 2;26(1):48-49. doi: 10.12968/bjcn.2021.26.1.48.
9
Rethinking the Current Older-people-first Policy for COVID-19 Vaccination in Japan.重新审视日本当前针对新冠疫苗接种的老年人优先政策。
J Epidemiol. 2021 Sep 5;31(9):518-519. doi: 10.2188/jea.JE20210263. Epub 2021 Jul 10.
10
[Defining priorities, the case of of COVID-19 vaccine].[确定优先事项，以新冠疫苗为例] （注：原文中“of of”表述有误，应改为“of”）
G Ital Cardiol (Rome). 2021 Jun;22(6):509-510. doi: 10.1714/3612.35936.
引用本文的文献
1
COVID-19 Vaccine Acceptance, Hesitancy, and Uptake in People with Diabetes in Australia.澳大利亚糖尿病患者对新冠病毒疫苗的接受度、犹豫态度及接种情况
Vaccines (Basel). 2024 Jun 16;12(6):662. doi: 10.3390/vaccines12060662.
2
Endothelium dysfunction and thrombosis in COVID-19 with type 2 diabetes.2 型糖尿病合并 COVID-19 患者的血管内皮功能障碍与血栓形成。
Endocrine. 2023 Oct;82(1):15-27. doi: 10.1007/s12020-023-03439-y. Epub 2023 Jul 1.
3
COVID-19 vaccine coverage, safety, and perceptions among patients with diabetes mellitus in China: a cross-sectional study.中国糖尿病患者的 COVID-19 疫苗接种率、安全性和认知情况：一项横断面研究。
Front Endocrinol (Lausanne). 2023 Jun 1;14:1172089. doi: 10.3389/fendo.2023.1172089. eCollection 2023.
4
Effect of COVID-19 vaccine on blood glucose metrics in Arabic people with type 1 diabetes.COVID-19 疫苗对 1 型糖尿病阿拉伯人群血糖指标的影响。
Front Endocrinol (Lausanne). 2023 Mar 20;14:1120384. doi: 10.3389/fendo.2023.1120384. eCollection 2023.
5
The Difference of COVID-19 Vaccination Attitude, Preventive Measures and Knowledge of SARS-COV-2 Between Diabetic Patients and Healthy Citizens in China.中国糖尿病患者与健康公民在新冠病毒疫苗接种态度、预防措施及对严重急性呼吸综合征冠状病毒2的认知方面的差异
J Multidiscip Healthc. 2023 Feb 23;16:493-502. doi: 10.2147/JMDH.S394790. eCollection 2023.
6
Uptake of Heterologous or Homologous COVID-19 Booster Dose and Related Adverse Events Among Diabetic Patients: A Multicenter Cross-Sectional Study - China, 2022.2022年中国糖尿病患者中新冠病毒异源或同源加强针接种情况及相关不良事件：一项多中心横断面研究
China CDC Wkly. 2023 Jan 6;5(1):5-10. doi: 10.46234/ccdcw2023.002.
7
Booster vaccination with inactivated whole-virus or mRNA vaccines and COVID-19-related deaths among people with multimorbidity: a cohort study.加强针接种灭活全病毒疫苗或 mRNA 疫苗与合并多种基础疾病人群的 COVID-19 相关死亡：一项队列研究。
CMAJ. 2023 Jan 30;195(4):E143-E152. doi: 10.1503/cmaj.221068.
8
Vaccination, symptomatic infection and negative conversion of viral RNA by body mass index, diabetes, and age: An observational study.体重指数、糖尿病和年龄对疫苗接种、症状感染和病毒 RNA 阴性转换的影响：一项观察性研究。
Vaccine. 2022 Nov 15;40(48):6900-6907. doi: 10.1016/j.vaccine.2022.10.014. Epub 2022 Oct 21.
9
Recent Progress in the Diagnosis and Management of Type 2 Diabetes Mellitus in the Era of COVID-19 and Single Cell Multi-Omics Technologies.2019冠状病毒病（COVID-19）和单细胞多组学技术时代2型糖尿病诊断与管理的最新进展
Life (Basel). 2022 Aug 8;12(8):1205. doi: 10.3390/life12081205.
10
BNT162b2 mRNA COVID-19 Vaccine Does Not Impact the Honeymoon Phase in Type 1 Diabetes: A Case Report.BNT162b2信使核糖核酸新冠疫苗对1型糖尿病蜜月期无影响：一例报告
Vaccines (Basel). 2022 Jul 8;10(7):1096. doi: 10.3390/vaccines10071096.
Zotero 插件